Cheri Walker, Chuck Piazza, Don Daut, William Emhiser, Timothy Haines, Stephen Oldfield, Gustavo Salem, Applied Biosystems, Promega, Beckman, ITN, Invitrogen, ReliaGene, Agilent | GenomeWeb

Cheri Walker has been named vice president of mergers and acquisitions of Qiagen. Walker joined the firm last week from Invitrogen, where she most recently held the position of vice president of proteomics. She had joined Invitrogen in December 2003 as vice president, corporate development. Prior to working at Invitrogen, Walker was an equity analyst with Deutsche Bank covering the life sciences tools industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.